Song Y M, Sheu W H
Department of Medicine, Taichung Veterans General Hospital, Taiwan.
Kaohsiung J Med Sci. 2000 Apr;16(4):203-9.
We report a case of a pituitary tumor cosecreting thyrotropin and prolactin with clinical manifestation of thyrotoxicosis, which is a very rare clinical disorder. Octreotide therapy is effective in suppressing the secretion of thyrotropin, prolactin, and thyroid hormones, and by this, renders relief of symptoms and complications of thyrotoxicosis.
我们报告一例垂体肿瘤同时分泌促甲状腺激素和催乳素,临床表现为甲状腺毒症的病例,这是一种非常罕见的临床病症。奥曲肽治疗可有效抑制促甲状腺激素、催乳素和甲状腺激素的分泌,从而缓解甲状腺毒症的症状和并发症。